Research analysts at StockNews.com assumed coverage on shares of NantHealth (NASDAQ:NH – Get Free Report) in a research note issued to investors on Tuesday. The brokerage set a “hold” rating on the stock.
NantHealth Trading Down 48.5 %
Shares of NASDAQ:NH opened at $0.34 on Tuesday. NantHealth has a 12-month low of $1.24 and a 12-month high of $9.75. The company has a market capitalization of $2.62 million, a PE ratio of -0.04 and a beta of 1.82. The business has a 50 day moving average of $0.39 and a two-hundred day moving average of $0.39.
Institutional Inflows and Outflows
Large investors have recently made changes to their positions in the business. Susquehanna International Group LLP acquired a new position in shares of NantHealth during the 1st quarter worth approximately $25,000. Goldman Sachs Group Inc. acquired a new position in shares of NantHealth during the 2nd quarter worth approximately $36,000. Millennium Management LLC acquired a new position in shares of NantHealth during the 2nd quarter worth approximately $110,000. Finally, Atria Wealth Solutions Inc. acquired a new position in shares of NantHealth during the 1st quarter worth approximately $170,000. 4.50% of the stock is owned by institutional investors and hedge funds.
NantHealth Company Profile
NantHealth, Inc engages in the provision of enterprise solutions that help businesses transform complex data into actionable insights. It is also involved in marketing solutions as a comprehensive integrated solution that includes clinical decision support, payer engagement solutions, data analysis, and network monitoring and management.
Featured Stories
- Five stocks we like better than NantHealth
- Why Are Stock Sectors Important to Successful Investing?
- The Charles Schwab Company Can Hit New Highs
- Investing in Construction Stocks
- Costco vs. Walmart: Revenue Comparison of Two Retail Giants
- How to Most Effectively Use the MarketBeat Earnings Screener
- 3 Energy Plays for Cash Flow: Buy 1 or Buy Them All
Receive News & Ratings for NantHealth Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for NantHealth and related companies with MarketBeat.com's FREE daily email newsletter.